The United Nations Industrial Development Organization (UNIDO) highlighted Cuba science’s ability to develop four anti-COVID-19 vaccine candidates, among them Soberana 02, soon to enter Phase III trials and bound to be the first Latin American vaccine against the SARS-CoV-2 virus.